Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
814.00    -5.00 (-0.61%)
Bid:
816.00
Ask:
817.00
Spread: 1.00 (0.123%)
Market Cap: £767.09m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AUM Update

17 Oct 2013 07:00

RNS Number : 6606Q
Polar Capital Holdings PLC
17 October 2013
 



17 October 2013

 

Polar Capital Holdings plc

AUM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

Group AUM (unaudited)

 

As at 30 September 2013 the Group's AUM increased by 58% to $11.4bn from the $7.2bn reported at 31 March 2013. This also represents over a 100% increase in AUM from the $5.3bn reported at 30 September 2012.

 

The table below sets out the movements in the Group's AUM over the six month period:

 

AUM movement

Six months to 30 September 2013

Long only funds

$m

Alternative funds

$m

Total

$m

As at 31 March 2013

$6,371m

$837m

$7,208m

Net subscriptions

$3,239m

$6m

$3,245m

Market movement and performance

$916m

$39m

$955m

Total AUM at 30 September 2013

$10,526m

$882m

$11,408m

 

Comment

 

Polar Capital recorded $3.2bn of net inflows in its first half year with a surprisingly high level of inflows in the historically slower summer second quarter amounting to $1.4bn.

 

In the quarter just commenced the Group's UK team will be leaving Polar Capital. It is not currently expected that a replacement UK team will be recruited. This will result in an outflow (at current market levels) of $293m of AUM in the December quarter.

 

Our overall strategy continues to be based on the presence of ten to twelve world class investment teams. The departure of the UK team will leave ten teams in place leaving further scope to add additional teams should the opportunity arise.

 

Given the renewed uncertainly in markets over recent weeks we would expect the levels of net inflows to be less certain and possibly materially lower in the upcoming quarters notwithstanding the loss of the UK related assets. The Group believes that despite this qualification it remains well positioned to grow both assets and profitability further over the longer term.

 

 

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fees (after the deduction of staff interests) earned and accrued in the first six months of the Group's financial year. The majority of the Group's performance fees crystallise in the second half of the financial year.

 

Performance fees

net of staff allocations

Six months to

30 Sept 12

£m

Year to

31 Mar 13

(year-end)

£m

Six months to

30 Sept 13

£m

Received

£0.0m

£5.5m

£0.0m

Accrued but not yet earned in funds with year ends on or before the financial year end

£4.2m

n/a

£4.5m

Total net performance fees

£4.2m

£5.5m

£4.5m

 

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO)John Mansell (CFO)

Canaccord Genuity - Nomad and Broker

Simon Bridges (QE)

Martin Green

Cameron Duncan

F T I Consulting

Neil Doyle

Jack Hickey

 

 

+44 (0)20 7227 2700

 

 

+44 (0)20 7523 8000

 

 

+44 (0)20 7269 7132

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAFEKFEFDFFF
Date   Source Headline
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results
19th Oct 20222:52 pmRNSDirector/PDMR Shareholding
13th Oct 20227:00 amRNSAuM Update
29th Sep 202210:33 amRNSHolding(s) in Company
7th Sep 20224:18 pmRNSResult of AGM
31st Aug 20222:03 pmRNSForm 8.3 - Diurnal Group PLC
26th Aug 20229:20 amRNSHolding(s) in Company
1st Aug 20227:00 amRNSBlock listing Interim Review
21st Jul 202212:14 pmRNSDirector/PDMR Shareholding - Replacement
20th Jul 202210:57 amRNSDirector/PDMR Shareholding
20th Jul 202210:26 amRNSDirector/PDMR Shareholding
14th Jul 20224:11 pmRNSHolding(s) in Company
14th Jul 20227:00 amRNSAuM Update
13th Jul 20223:25 pmRNSForm 8.3 - Serica Energy PLC
13th Jul 202210:23 amRNSDirector/PDMR Shareholding
6th Jul 20225:50 pmRNSDirector/PDMR Shareholding
29th Jun 20221:10 pmRNSHolding(s) in Company
27th Jun 20227:00 amRNSGroup Audited Results for year ended 31 March 2022
21st Jun 20227:00 amRNSInvestor Presentation covering Preliminary Results
15th Jun 202210:59 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.